High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients

Clinical trial NCT05215327 · RECRUITING

Trial details

NCT number: NCT05215327
Sponsor: Vanderbilt University Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Immunization; Infection Transplantation Infection Influenza

Start date: 2022-11-08
Primary completion: 2027-07-31
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.